Hydroxyurea Use After Transitions of Care Among Young Adults With Sickle Cell Disease and Tennessee Medicaid Insurance

JAMA Netw Open. 2021 Oct 1;4(10):e2128971. doi: 10.1001/jamanetworkopen.2021.28971.

Abstract

This cohort study examines whether hydroxyurea use changes in young adults with sickle cell disease who are transitioning from pediatric to adult health care.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Adolescent
  • Adult
  • Anemia, Sickle Cell / drug therapy*
  • Anemia, Sickle Cell / epidemiology
  • Antisickling Agents / administration & dosage
  • Cohort Studies
  • Female
  • Humans
  • Hydroxyurea / administration & dosage*
  • Male
  • Medicaid / statistics & numerical data*
  • Patient Transfer / methods
  • Patient Transfer / trends
  • Statistics, Nonparametric
  • Tennessee / epidemiology
  • United States

Substances

  • Antisickling Agents
  • Hydroxyurea